TP53 rs1042531: Role in Reproductive Traits
rs1042531 is a single nucleotide variant located within the human TP53 gene on chromosome 17. The variant is in strong linkage disequilibrium with the widely researched TP53 codon 72 polymorphism, a locus studied for its subtle functional impacts on cellular apoptosis and embryo implantation. While preliminary studies associate this pathway with reproductive traits such as blastocyst implantation competence, clinical evidence remains limited and observational.
What each genotype means
Proline-homozygous genotype
This genotype results in the expression of the proline-encoding variant at codon 72 of the TP53 protein. Research suggests this variant may have different biochemical properties compared to the arginine-encoding variant, with some studies associating it with variations in blastocyst implantation competence and potential risk for recurrent implantation failure. These findings are based on statistical associations in specific populations and should not be used to predict individual reproductive outcomes.
This genotype is common globally, though its frequency varies significantly by ancestry, being more prevalent in certain populations compared to others.
Proline-arginine heterozygous genotype
This genotype indicates you carry one copy of the proline-encoding allele and one copy of the arginine-encoding allele at codon 72 of the TP53 gene. Scientific literature has investigated whether this balance of p53 protein variants influences cellular processes like embryo implantation, though evidence remains limited and mixed regarding its clinical significance. As with all genetic associations, this does not determine your personal health or reproductive success.
This heterozygous state is frequently observed across diverse global populations, often representing a significant portion of the population frequency for this variant.
Arginine-homozygous genotype
This genotype results in the expression of the arginine-encoding variant at codon 72 of the TP53 protein. Some research has explored whether this specific form of the p53 protein is associated with different rates of blastocyst implantation or susceptibility to recurrent implantation failure compared to the proline-encoding form. Current evidence is limited and inconsistent, meaning this genotype is not a diagnostic indicator of reproductive health.
This genotype is widely distributed, with its prevalence being a major contributor to the overall population frequency of this TP53 variant.
Genomic Location and the TP53 Gene
The rs1042531 variant is located within the TP53 gene on chromosome 17p13.1. TP53 encodes the tumor protein p53, often termed the 'guardian of the genome.' p53 functions primarily as a transcription factor that orchestrates cellular responses to stress, DNA damage, and metabolic shifts by regulating cell cycle arrest, DNA repair, senescence, and programmed cell death (apoptosis). In human genetics, common non-pathogenic variants in TP53 do not typically cause classical Li-Fraumeni syndrome—which arises from rare, high-penetrance loss-of-function mutations—but instead act as functional modifiers. rs1042531 sits in close proximity and tight linkage disequilibrium with the well-characterized functional polymorphism at codon 72 (rs1042522, Arg72Pro), frequently co-segregating with regulatory haplotypes across the locus.
Linkage to Codon 72 and Implantation Biology
Research over the past two decades has highlighted a distinct non-oncological role for p53 signaling: the regulation of reproduction. In murine models and human in vitro studies, p53 regulates the expression of leukemia inhibitory factor (LIF), a cytokine critical for blastocyst implantation into the receptive uterine endometrium. The codon 72 variants, which are linked to rs1042531 haplotypes, exhibit biochemically distinct behaviors. The Arginine (Arg) allele induces apoptosis with higher efficiency, whereas the Proline (Pro) allele is associated with lower transcriptional activation of specific apoptotic targets and differential vascular remodeling. Because successful embryo implantation requires a tightly calibrated balance between endometrial apoptosis, trophoblastic invasion, and angiogenesis, researchers hypothesize that naturally occurring variants in this pathway modulate reproductive efficiency.
Research on Implantation and Fertility Traits
Several candidate gene investigations have evaluated whether alleles at the TP53 codon 72 locus and associated variants like rs1042531 correlate with in vitro fertilization (IVF) outcomes, recurrent implantation failure (RIF), or recurrent pregnancy loss (RPL). Some clinical studies have reported that individuals homozygous for the Proline-linked haplotype experience higher rates of recurrent implantation failure following embryo transfer compared to carriers of the Arginine allele. However, the overall strength of this evidence remains classified as limited. Findings across cohorts are mixed, characterized by modest sample sizes, variable treatment protocols, and lack of genome-wide significance in unselected populations. Therefore, these findings represent subtle statistical tendencies rather than definitive causal determinants.
Clinical Interpretation and Limitations
It is critical for individuals reviewing genetic data to understand the boundary between statistical research associations and clinical utility. Carrying a particular genotype at rs1042531 or codon 72 is neither a medical diagnosis nor a guarantee of fertility challenges. Embryo implantation is a multifactorial biological event governed by embryonic ploidy, maternal endocrine health, immunological factors, uterine anatomy, and lifestyle elements. Because evidence for rs1042531 is observational and limited, professional clinical guidelines do not recommend altering fertility treatments, medication protocols, or IVF regimens based solely on this locus. Anyone undergoing fertility treatment should interpret these results as exploratory research and consult a reproductive endocrinologist or certified genetic counselor for validated clinical care.
How common is this variant?
The minor allele frequency for rs1042531 ranges approximately from 0.35 to 0.45 across global human populations. Frequencies of this locus and its linked codon 72 haplotypes vary substantially across continental ancestries, displaying a well-documented latitudinal gradient with higher Pro-linked frequencies in populations near the equator.
Frequently asked questions
Does having the rs1042531 variant cause infertility?
No. Carrying this variant does not cause infertility. Research studies have observed minor statistical associations between TP53 regulatory haplotypes and blastocyst implantation rates during assisted reproduction, but many individuals with any genotype conceive naturally without difficulty.
Is rs1042531 related to cancer risk like other TP53 mutations?
Unlike the rare, severe pathogenic mutations that cause Li-Fraumeni syndrome, rs1042531 is a common, benign-to-mild functional modifier present in a large percentage of the general population. It is studied for subtle variations in normal cellular pathways rather than hereditary cancer predisposition.
Should I change my IVF protocol if I carry the variant?
No. Clinical fertility guidelines do not recommend modifying medications, embryo transfer techniques, or IVF timing based on rs1042531 genotypes. Any questions regarding assisted reproductive technology or medication dosing should always be addressed with your reproductive endocrinologist.
Why is the evidence for this variant listed as limited?
The evidence is considered limited because most associations stem from small, observational candidate gene studies that have not always replicated across larger, diverse populations. Multifactorial traits like implantation success involve thousands of interacting genetic and physiological factors.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042531?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
Pathogenic missense variant (p.Arg248Gln) associated with Li-Fraumeni syndrome.
Functional codon 72 polymorphism (Arg72Pro) affecting apoptotic capability and associated with differential susceptibility to multiple cancer types.
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.
Pathogenic hotspot variant (p.Arg273His) in TP53 predisposing carriers to early-onset sarcomas, breast cancers, and leukemias.
Li-Fraumeni syndrome missense variant (p.Arg248Trp) causing loss of tumor suppressor function and multi-cancer predisposition.
3' UTR hypomorphic variant in TP53 that impairs proper polyadenylation and significantly confers elevated risk for basal cell carcinoma, glioma, and other cancers.